I. Claus, “Metabolomics for Distinguishing Cardiovascular Risk in Rheumatoid Arthritis Across Different Disease-Modifying Antirheumatic Drug Therapies”, J Clin Med Res, vol. 17, no. 2, pp. 89–96, Feb. 2025, doi: 10.14740/jocmr6145.